Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AstraZeneca PLC - American Depositary Shares
(NY:
AZN
)
185.41
-3.53 (-1.87%)
Streaming Delayed Price
Updated: 12:22 PM EDT, Mar 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AstraZeneca PLC - American Depositary Shares
The Great Unbundling: How AI’s Insatiable Hunger is Driving a Corporate Divestiture Gold Rush
March 18, 2026
As of March 18, 2026, the corporate landscape has undergone a radical transformation. The era of the sprawling global conglomerate, once the gold standard of industrial stability, is rapidly giving way...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Could This International ETF Be One of the Best Investments of 2026?
↗
March 14, 2026
International stocks look attractively valued in an expensive market environment.
Via
The Motley Fool
Topics
ETFs
The 'Sentiment Trap': Why Beating Earnings Is No Longer Enough in the Age of AI Sentiment Analysis
March 13, 2026
In the high-stakes theater of corporate earnings calls, a "beat" on the bottom line used to be a guaranteed ticket to a stock price rally. However, as we move through the first quarter of 2026, a new...
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Regulatory Compliance
The Billion-Dollar Divide: How "Megadeals" Are Defining a K-Shaped M&A Market in 2026
March 11, 2026
The opening months of 2026 have revealed a startling paradox in the global financial landscape: while the sheer number of corporate marriages is dwindling, the price tags on the few remaining...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity
March 10, 2026
As of today, March 10, 2026, Pfizer Inc. (NYSE: PFE) stands at a pivotal crossroads in its 177-year history. After experiencing a meteoric rise during the COVID-19 pandemic followed by a sobering...
Via
Finterra
Topics
Economy
Intellectual Property
Lawsuit
The Great Rotation: Why Global Capital is Deserting US Tech for International Value in 2026
March 05, 2026
As of early March 2026, the long-standing dominance of the S&P 500 (NYSEARCA: VOO) has met its most significant challenge in nearly a decade. For the first time since the mid-2010s, international...
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Compugen (CGEN) Q4 2025 Earnings Call Transcript
↗
March 02, 2026
Compugen (CGEN) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
As Investors Flee U.S. Equities, This Global ETF Is Outperforming
↗
March 02, 2026
Via
MarketBeat
Topics
ETFs
After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound
↗
February 27, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy
February 26, 2026
In a move that solidifies a new standard of care for a high-risk patient population, the U.S. Food and Drug Administration (FDA) has granted full approval to Pfizer Inc. (NYSE: PFE) for its BRAFTOVI...
Via
MarketMinute
Topics
Economy
Intellectual Property
AstraZeneca’s Strategic Leap: Pharmaceutical Giant Completes Historic Move to the New York Stock Exchange
February 26, 2026
On February 2, 2026, AstraZeneca PLC (NYSE: AZN) officially rang the opening bell at the New York Stock Exchange, marking the completion of its high-profile transition from the Nasdaq. The move signals...
Via
MarketMinute
Topics
ETFs
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
February 25, 2026
In a definitive move to dominate the next frontier of immunology and oncology, Eli Lilly and Company (NYSE: LLY) announced on February 9, 2026, its acquisition of Orna Therapeutics for a total...
Via
MarketMinute
Topics
Intellectual Property
ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
February 16, 2026
As the oncology community prepares to descend upon San Francisco for the 2026 ASCO Genitourinary (GU) Cancers Symposium from February 26–28, investors and clinicians alike are bracing for data that...
Via
MarketMinute
Topics
Intellectual Property
Buy 2 Vanguard Index Funds to Beat the S&P 500 in the Next Decade, According to Wall Street Analysts
↗
February 16, 2026
Goldman Sachs expects European and emerging-market equities to beat the U.S. stock market over the next decade.
Via
The Motley Fool
Topics
ETFs
Stocks
The Great 2026 Divergence: Tech Titans Rise on AI Execution While Healthcare Reaps a Regulatory Whirlwind
February 13, 2026
As the opening bell rang on February 13, 2026, the divergence between the U.S. technology and healthcare sectors reached a historic fever pitch, signaling a fundamental shift in how markets price...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
↗
February 12, 2026
Via
MarketBeat
Alnylam Pharmaceuticals (ALNY): The RNAi Pioneer’s 2026 Breakout and the Battle for Cardiovascular Dominance
February 12, 2026
As of February 12, 2026, Alnylam Pharmaceuticals (NASDAQ: ALNY) has officially transcended its status as a high-potential biotech and entered the pantheon of global pharmaceutical powerhouses. Known as...
Via
Finterra
Topics
Economy
Intellectual Property
The Great Rebound: 2026 Becomes the Year of the Strategic Mega-Deal as M&A Activity Surges
February 11, 2026
As of February 11, 2026, the corporate landscape is undergoing its most significant transformation in half a decade. After two years of high interest rates and regulatory gridlock that chilled the...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
AstraZeneca Signals a New Era in Obesity Care: Earnings Report Teases Oral GLP-1 Powerhouse
February 10, 2026
On February 10, 2026, AstraZeneca (NYSE:AZN) delivered an earnings report that did more than just recap a successful fiscal year; it laid down a definitive challenge to the current titans of the...
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
February 10, 2026
Date: February 10, 2026 Introduction For years, Gilead Sciences, Inc. (Nasdaq: GILD) was characterized by investors as a "value trap"—a cash-rich biopharma giant that had lost its way after the...
Via
Finterra
Topics
Economy
Intellectual Property
The $80 Billion Ambition: An In-Depth Analysis of AstraZeneca (AZN) in 2026
February 10, 2026
Date: February 10, 2026 Introduction AstraZeneca PLC (NASDAQ: AZN; LSE: AZN) stands today at a critical crossroads of pharmaceutical history. Long recognized as the crown jewel of British...
Via
Finterra
Topics
Artificial Intelligence
Economy
Fraud
AstraZeneca’s Strategic Takeover of Modella AI Signals the Rise of Agentic Oncology
February 06, 2026
In a move that underscores the pharmaceutical industry’s aggressive pivot toward integrated artificial intelligence, AstraZeneca (NASDAQ: AZN) recently announced the full acquisition of Modella AI, a...
Via
TokenRing AI
Topics
Artificial Intelligence
The Phoenix of Big Pharma: A 2026 Deep-Dive into AstraZeneca’s Global Dominance
February 06, 2026
As of February 6, 2026, AstraZeneca PLC (NASDAQ: AZN) stands as a case study in corporate resilience and strategic reinvention. Once a company teetering on the edge of a massive patent cliff a decade...
Via
Finterra
Topics
Economy
Government
Intellectual Property
Trade War 2.0: 25% Tariffs on Chips, Cars, and Medicine Reshape the Global Supply Chain
February 05, 2026
The global economic landscape has been jolted in the opening weeks of 2026 as the United States government formalizes a series of aggressive 25% tariff proposals targeting the critical sectors of...
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
OAK Family Advisors Sells $4 Million of NICE Stock
↗
February 05, 2026
This software firm delivers AI-driven cloud platforms for enterprise customer engagement and compliance across global markets.
Via
The Motley Fool
Topics
Artificial Intelligence
Regulatory Compliance
US Trade Deficit Widens to -$56.8 Billion: A Surprise Drag on GDP Amid AI Infrastructure Surge
February 02, 2026
The U.S. economy faced a sobering reality check last week as the Bureau of Economic Analysis (BEA) released a trade report on January 29, 2026, revealing a deficit that widened far beyond initial...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
